Background Schizophrenia is a major psychiatric disorder with unknown aetiology. Recent
evidence suggests a potential role for cytokines in its pathophysiology and that antipsychotic …

Introduction The severity of positive symptoms in schizophrenia is associated with poor
prognosis. About one-third of schizophrenia patients partially respond to treatment with …

Background Despite intensive research, the etiological causes of autism spectrum disorder
(ASD) remain elusive. Immunological mechanisms have recently been studied more …

Treatment discontinuation is a major challenge in routine clinical settings. Despite poor
adherence to antipsychotic medication, long acting injectable (LAI) formulations are an …

Introduction The clinical course of schizophrenia is often characterized by recurrent
relapses. Blood inflammatory markers are altered in acute psychosis, and may be state …

There is evidence that subclinical inflammation and increased gut permeability might be
involved in the pathophysiology of schizophrenia. Less is known about these phenomena in …

Rationale Although the immune system is thought to contribute to the etiology of
schizophrenia, the mechanism has not been elucidated. Clarifying the relationship between …

Introduction: Immune alterations are associated with the progression of psychosis. However,
there are few studies designed to longitudinally measure inflammatory biomarkers during …

Background There is increasing evidence that immune dysfunction plays an important role
in the pathogenesis of schizophrenia. Meso Scale Discovery (MSD) is bioanalytical method …

Multi-disciplinary collaborative consensus guidance statement on the assessment and
treatment of mental health symptoms in patients with post-acute sequelae of SARS-CoV-2 …